BIFFI, MAURO
 Distribuzione geografica
Continente #
NA - Nord America 9.069
EU - Europa 7.774
AS - Asia 3.680
AF - Africa 481
SA - Sud America 25
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 6
Totale 21.047
Nazione #
US - Stati Uniti d'America 9.049
GB - Regno Unito 2.382
IT - Italia 1.480
VN - Vietnam 1.242
CN - Cina 1.174
DE - Germania 1.091
UA - Ucraina 809
SG - Singapore 691
SE - Svezia 600
IN - India 448
FR - Francia 362
RU - Federazione Russa 311
IE - Irlanda 290
EE - Estonia 215
CI - Costa d'Avorio 151
ZA - Sudafrica 143
TG - Togo 83
SC - Seychelles 72
FI - Finlandia 55
BG - Bulgaria 45
JO - Giordania 39
CH - Svizzera 37
IR - Iran 28
NG - Nigeria 27
BE - Belgio 22
CA - Canada 19
NL - Olanda 16
GR - Grecia 14
CL - Cile 11
RO - Romania 11
BR - Brasile 10
KR - Corea 10
AU - Australia 9
JP - Giappone 9
LB - Libano 8
HK - Hong Kong 7
UZ - Uzbekistan 7
CZ - Repubblica Ceca 6
AT - Austria 5
PL - Polonia 5
BD - Bangladesh 4
EU - Europa 4
AR - Argentina 3
EG - Egitto 3
HR - Croazia 3
NZ - Nuova Zelanda 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DK - Danimarca 2
ES - Italia 2
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
PT - Portogallo 2
SA - Arabia Saudita 2
TH - Thailandia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BZ - Belize 1
CO - Colombia 1
HU - Ungheria 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MU - Mauritius 1
PK - Pakistan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 21.047
Città #
Southend 2.147
Fairfield 1.166
Ashburn 894
Chandler 661
Singapore 614
Jacksonville 585
Wilmington 580
Woodbridge 530
Princeton 512
Houston 508
Seattle 505
Dong Ket 457
Cambridge 419
Ann Arbor 318
Dublin 289
Westminster 232
Padova 231
Nanjing 208
Abidjan 151
Berlin 143
Santa Clara 132
Saint Petersburg 122
Shenyang 118
Medford 115
Milan 103
Jinan 101
Mülheim 88
San Diego 87
Lomé 83
Changsha 78
Bologna 75
Bremen 73
Mahé 72
Beijing 69
Hebei 69
Nanchang 63
New York 63
Rome 59
Turin 56
Helsinki 54
Jiaxing 52
Des Moines 51
Boardman 46
Olalla 44
Sofia 43
Tianjin 40
Amman 39
Zhengzhou 36
Ningbo 33
Verona 29
Bari 27
Dearborn 27
Hangzhou 27
Abeokuta 26
Falls Church 25
Norwalk 25
Taizhou 25
Guangzhou 24
Haikou 24
Mountain View 24
Lanzhou 23
Brussels 22
Bern 18
San Venanzo 17
Bühl 16
Ardabil 15
Los Angeles 15
Shanghai 15
Florence 14
London 13
Monterotondo 13
Pune 13
Taiyuan 13
Toronto 13
Kunming 12
Monmouth Junction 12
Paris 11
Redwood City 11
Leawood 10
Naples 10
Chicago 9
Costa Mesa 9
Fuzhou 9
Genzano Di Roma 9
Hefei 9
Messina 9
Frankfurt am Main 8
Palermo 8
Phoenix 8
Plauen 8
Tokyo 8
Augusta 7
Catania 7
Groningen 7
Hyderabad 7
Kuban 7
Rho 7
Salerno 7
Frankfurt Am Main 6
Napoli 6
Totale 13.938
Nome #
Incremento dei valori di troponina T dopo impianto di pacemaker con elettrodi a fissaggio attivo e passivo. 734
Psychological correlates, allostatic overload and clinical course in patients with implantable cardioverter defibrillator (ICD) 280
Fattori predittivi di rimodellamento cardiaco inverso del ventricolo sinistro in pazienti candidati a terapia di resincronizzazione cardiaca: il ruolo dell’eziologia. 182
Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. 178
Atrial fibrillation and prediction of mortality by conventional clinical score systems according to the setting of care 164
AF burden is important - Fact or fiction? 154
Arrhythmia discrimination by physician and defibrillator: importance of atrial channel. 151
A changing scenario in the clinical use of implantable defibrillators: the need for long-term data on lead performance. 149
Biventricular ICDs and rhythm discrimination by analysis of QRS morphology: are there QRS changes associated with left ventricular reverse remodeling? Poster European Congress of Cardiology 2007 148
Cardiac resynchronization therapy: variations in echo-guided optimized atrioventricular and interventricular delays during follow-up. 148
Battery drain in daily practice and medium-term projections on longevity of cardioverterdefibrillators: An analysis from a remote monitoring database 143
Automatic verification of ventricular stimulation: fusion management algorithm 142
Atrial fibrillation ablation: beyond electro-mechanical matters 142
Assessment of regional left ventricular function by radionuclide angiography in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 140
Clinical implications of left superior vena cava persistence in candidates for pacemaker or cardioverter-defibrillator implantation 139
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study. 139
Acute changes in electromechanical parameters during different pacing configurations using a quadripolar left ventricular lead 135
Automatic management of left ventricular stimulation: hints for technologic improvement. 131
A comparison among three different echocardiographic methods for Interventricular delay optimization. Poster European Congress of Cardiology 2008 129
Atrial fibrillation in heart failure patients undergoing resynchronization therapy: what decision making? Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques 127
Atrial fibrillation and heart failure: does one epidemic feed he other? 127
A prospective randomized evaluation of VV delay optimization in CRT patients. Proceedings 16th World Congress in Cardiac Electrophysiology and Cardiac Techniques. 126
Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia 126
Automatic management of atrial and ventricular stimulation in a contemporary unselected population of pacemaker recipients: the ESSENTIAL Registry 123
How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint. 122
Effects of cardiac resynchronization therapy on diastolic function: evaluation by radionuclide angiography. 122
Cardiac resynchronization therapy in clinical practice: Need for electrical, mechanical, clinical and logistic synchronization. 120
Exercise stress echocardiography is superior to rest echocardiography in predicting left ventricular reverse remodelling and functional improvement after cardiac resynchronization therapy. 120
A new algorithm for ventricular capture detection in ICDs, in Proceedings XI International Symposium Progress in Clinical Pacing 119
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 119
Evaluation of fusion beat detection with a new ventricular automatic capture algorithm in ICDs. 118
Cardiac resynchronization therapy : effects on left and right ventricular ejection fraction during exercise 118
Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction" 118
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise 115
Implantable electrical devices for prevention of sudden cardiac death: data on implant rates from a 'real world' regional registry. 114
Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. 114
Algoritmi diagnostici nei defibrillatori mono e bicamerali: analisi delle capacità di discriminazione delle aritmie sopraventricolari e ventricolari. 114
The "Subtle" connection between development of cardiac implantable electrical device infection and survival after complete system removal: An observational prospective multicenter study 113
Valutazione angiocardioscintigrafica dei pazienti sottoposti aterapia di resincronizzazione cardiaca; esperienza del centro di Bologna. 111
Automatic management of left ventricular pacing output: effectiveness of stimulation and device longevity. Proceedings XIII International symposium on Progress in Clinical Pacing 111
Cardiac resynchronization therapy: is systole all that matters? 110
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. 110
Decrease in patient radiation exposure by a tantalum filter during electrophysiological procedures. 109
A plateau waveform shape allows a much higher patient shock energy tolerance 109
Contribution of PET imaging to mortality risk stratification in candidates to lead extraction for pacemaker or defibrillator infection: a prospective single center study 109
Automatic verification of ventricular stimulation: fusion management algorithm 108
Evaluation of the atrial evoked response for capture detection with high-polarization leads. 107
Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis? 107
Outcome of cardioverter-defibrillator implant in patients with arrhythmogenic right ventricular cardiomyopathy. 107
Cardiac resynchronization therapy and VV interval optimization: which relationship between QRS width and the results of echo-guided VV interval optimization? 106
How to truly value implantable cardioverter-defibrillators technology: Up-front cost or daily cost? 106
Repolarization effects of multiple-cycle chemotherapy and predictors of QTc prolongation: A prospective female cohort study on >2000 ECGs 106
Resincronizzazione cardiaca con pacing biventricolare o ventricolare sinistro: effetti a medio termine su funzione sistolica e sincronia ventricolare sinistra 105
Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death 105
Expenditure and value for money: the challenge of implantable cardioverter defibrillators 105
Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial. 105
Cardiac resynchronization therapy: a cost or an investment? 105
Fibrillazione atriale e terapia di resincronizzazione cardiaca: quale strategia? 105
Atrial fibrillation: Adverse effects of "pill-in-the-pocket" treatment and propafenone-carvedilol interaction. 104
Left ventricular rotational mechanics in acute myocardial infarction and in chronic (ischemic and nonischemic) heart failure patients. 104
The QRS interval in patients treated with resynchronization therapy: which value 103
Implantation of cardioverter-defibrillator: Effects on shoulder function. 103
Management of Phrenic Stimulation in CRT Patients over the Long Term: Still an Unmet Need ? 103
Cardioversione elettrica associata ad impianto di dispositivo per resincronizzazione cardiaca: quali risultati a distanza? 103
Less is more: Can we achieve cardiac resynchronization with 2 leads only? 103
Role of drugs and devices in patients at risk of sudden cardiac death. 103
Cardiac resynchronisation therapy: effect on diastolic function –Evaluation by radionuclide angiography 102
Cardioversione elettrica di fibrillazione atriale associata ad impianto di dispositivo per la resincronizzazione cardiaca: quali i risulatati a lungo termine? 102
Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectives. 102
Effects of cardiac resynchronisation therapy on dilated cardiomyopathy with isolated ventricular non-compaction. 102
Cardiac resynchronisation therapy: effect on intra-ventricular and inter-ventricular dyssynchrony at radionuclide angiography by Fourier phase analysis 101
Delayed asymptomatic migration of an implantable cardioverter-defibrillator lead to the costophrenic angle. 100
Incidence and clinical relevance of uncontrolled ventricular rate during atrial fibrillation in heart failure patients treated with cardiac resynchronization therapy. 100
Improving stroke risk stratification using the CHADS2 and CHA2DS2-VASc risk scores in patients with paroxysmal atrial fibrillation by continuous arrhythmia burden monitoring. 100
Analisi costi-benefici dell’impianto di cardioverter-defibrillatore 100
Outcomes with dronedarone in atrial fibrillation: What differences between real-world practice and trials? A meta-analysis and meta-regression analysis 100
Effects of cardiac resynchronization therapy on left ventricular twist. 99
Cardiac resynchronization therapy: update on clinical studies 99
Acute automatic capture verification performance using left ventricular pacing leads 99
From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems 98
Clinical and therapeutic implications of troponin elevation in cardiac arrest 98
Prediction of atrial fibrillation in patients with an implantable cardioverter-defibrillator and heart failure. 97
From lead management to implanted patient management: systematic review and meta-analysis of the last 15 years of experience in lead extraction 97
A plateau waveform shape allows a much higher patient shock energy tolerance. Poster 2872 97
Atrial fibrillation in patients with cardiac resynchronization therapy: Clinical management and outcome 97
Contribution of morphology discrimination algorithm for improving rhythm discrimination in slow and fast ventricular tachycardia zones in dual-chamber implantable cardioverter-defibrillators. 96
Is cardiac resynchronization therapy cost-effective? 95
Phrenic stimulation: a challenge for cardiac resynchronization therapy 95
Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems. 94
Effect of cardiac resynchronization therapy on subendo- and subepicardial left ventricular twist mechanics and relation to favorable outcome. 93
The challenge of preventing stroke in elderly patients with atrial fibrillation. 93
Peri-operative management of patients taking antithrombotic therapy: need for an integrated proactive approach. 92
Atrial evoked response signal quality in heart failure patients 91
Meta-analysis of randomized controlled trials evaluating left ventricular vs. biventricular pacing in heart failure: effect on all-cause mortality and hospitalizations. 91
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients 91
Impact of mitral regurgitation on the outcome of patients treated with CRT-D: data from the InSync ICD Italian Registry. 90
Short-spaced dipole for managing phrenic nerve stimulation in patients with CRT: The "phrenic nerve mapping and stimulation EP" catheter study. 90
Left ventricular pacing rate lower than expected during manual pacing threshold test in a biventricular defibrillator. 89
Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity! 89
Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization 89
Totale 12.043
Categoria #
all - tutte 49.287
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.287


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.536 0 0 124 351 446 531 599 684 648 375 188 590
2020/20213.486 719 209 85 171 50 141 43 174 206 180 144 1.364
2021/20223.655 340 192 257 282 352 256 67 285 109 139 613 763
2022/20233.778 405 475 208 492 196 241 108 209 666 194 332 252
2023/20241.084 88 176 75 75 118 189 78 60 64 61 41 59
2024/20251.354 177 923 254 0 0 0 0 0 0 0 0 0
Totale 21.430